Bacterin to Present at the LD Micro Conference BELGRADE, MT

at the LD Micro Conference

BELGRADE, MT, November

26, 2013 -- Bacterin International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone grafts

and coatings for medical applications, today announced that its CEO, Dan Goldberger, and CFO, John Gandolfo, will present at the

LD Micro Conference, to be held December 3-5, 2013 at the Luxe Sunset Bel Air in Los Angeles. Bacterin's presentation will take

place Thursday, December 5, 2013 at 1:30 PM PST.

A live broadcast of the

conference presentation will be available. To access the broadcast, go to the "Investor Info" section of the Company's

website at www.bacterin.com. A replay of the conference presentation will also be available.

About Bacterin International

Bacterin International

Holdings, Inc. (NYSE MKT: BONE) develops, manufactures and markets biologics products to domestic and international markets. Bacterin's

proprietary methods optimize the growth factors in human allografts to promote bone, subchondral repair and dermal growth. These

products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain, promotion of bone

growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other

Bacterin's Medical Device

division develops and licenses coatings for various medical device applications. For further information, please visit www.bacterin.com.